Neurology
Home Neurology
Lifesaving Drug for Infants Costs $2.1 Million a Dose
When Zolgensma was approved, maker Novartis said it expected insurance companies to cover the cost
Authors Say Lower BP Targets May Cut Recurrent Stroke Risk
Data from randomized trial with nonsignificant findings added to updated meta-analysis
Testosterone Replacement Therapy May Increase Cardiovascular Risk
Increased risk in men on TRT for composite of heart attack, ischemic stroke, transient ischemic attack
Review Examines Methods for Diagnosis of Elevated ICP in Critically Ill
Physical examination features not sensitive enough for diagnosis of elevated ICP in critically ill patients
Metformin May Lower Dementia Risk in Black Patients With T2DM
Findings strongest in younger African-American patients aged 50 to 64 years
CDC: Mortality Rates Continue to Decrease for Hispanic Adults
Difference in death rates between non-Hispanic white, Hispanic adults widened from 2000 to 2017
FDA Warns CBD Product Maker About False Claims
Agency says unproven claims about CBD products could lead consumers to delay medical care
Adiposity in Early Old Age Tied to MRI Signs of Brain Aging Later
Higher BMI, larger waist circumference in one's 60s significantly associated with cortical thinning
Stimulant Treatment Has Strong Protective Effect in ADHD
Number needed to treat was low and varied from three to 10 for youth with ADHD
Initiating Stroke Tx 15 Minutes Earlier Can Improve Outcomes
Findings seen in patients with acute ischemic stroke treated with endovascular-reperfusion therapy
